RecruitingNot ApplicableNCT05390424
Screening for Hepatitis B, Hepatitis C and AIDS Viruses Using Dried Blood Spot
Sponsor
University Hospital, Rouen
Enrollment
500 participants
Start Date
Dec 2, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The aim of the study is to screen for hepatitis B, hepatitis C and AIDS viruses using a Dried Blood Spot in drug users
Eligibility
Min Age: 18 Years
Plain Language Summary
Simplified for easier understanding
This study is testing whether a rapid, non-invasive saliva-based test can reliably screen for hepatitis B, hepatitis C, and HIV — making it easier for people who use drugs to get tested, since they may have difficulty accessing traditional blood draw testing at a clinic.
**You may be eligible if...**
- You are a current or former intravenous or nasal drug user
- OR you are currently receiving medication-assisted treatment for opioid dependence (such as methadone or buprenorphine)
**You may NOT be eligible if...**
- You are already known to have an active viral infection (hepatitis B, hepatitis C, or HIV)
Talk to your doctor to see if this trial is right for you.
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
DIAGNOSTIC_TESTBlood collection using Dried Blood Spot
Drug users will be screened for Hepatitis C, Hepatitis B and AIDS using Dried Blood Spot for blood collection
Locations(11)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05390424
Related Trials
Evaluation of Patients With Liver Disease
NCT000019711 location
hUC Mesenchymal Stem Cells (19#iSCLife®-LC) in the Treatment of Decompensated Hepatitis b Cirrhosishepatitis b Cirrhosis
NCT038264331 location
Study of the Pharmacokinetics and Safety of Glecaprevir/Pibrentasvir Initiated in Pregnancy in Women With Hepatitis C With and Without HIV
NCT0704031910 locations
The Collaborative Care PrTNER Study
NCT065856312 locations
C-Forward: Efficacy and Safety of BEM/RZR vs SOF/VEL in Subjects With Chronic HCV
NCT07037277106 locations